Lawrence M. Halpern

845 total citations
27 papers, 607 citations indexed

About

Lawrence M. Halpern is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Lawrence M. Halpern has authored 27 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cellular and Molecular Neuroscience, 8 papers in Psychiatry and Mental health and 5 papers in Molecular Biology. Recurrent topics in Lawrence M. Halpern's work include Neuroscience and Neuropharmacology Research (11 papers), Epilepsy research and treatment (8 papers) and Neural dynamics and brain function (3 papers). Lawrence M. Halpern is often cited by papers focused on Neuroscience and Neuropharmacology Research (11 papers), Epilepsy research and treatment (8 papers) and Neural dynamics and brain function (3 papers). Lawrence M. Halpern collaborates with scholars based in United States, Norway and France. Lawrence M. Halpern's co-authors include R. Julien, Seth K. Sharpless, Richard G. Black, Cornelis B. Bakker, Albert S. Carlin, Robin D. Post, Allan S. Troupin, James Robinson, Arthur A. Ward and John R. Green and has published in prestigious journals such as Science, Pain and Journal of Abnormal Psychology.

In The Last Decade

Lawrence M. Halpern

27 papers receiving 542 citations

Peers

Lawrence M. Halpern

CMN

PMH

PPCH

Carl F. Essig United States

Isaac L. Crawford United States

Barbara A. Bennett United States

Hiroshi Fukuzako Japan

F Rinaldi Italy

John Carmody Australia

S E Lukas United States

Matthew Fairchild United States

Zipora Speiser Israel

C. Albano Italy

Carl F. Essig United States

Lawrence M. Halpern

251 ×0.8

CMN

190 ×1.2

PMH

106 ×0.7

99 ×0.9

55 ×0.6

PPCH

Citations per year, relative to Lawrence M. Halpern Lawrence M. Halpern (= 1×) peers Carl F. Essig

Countries citing papers authored by Lawrence M. Halpern

Since Specialization

Citations

This map shows the geographic impact of Lawrence M. Halpern's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lawrence M. Halpern with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lawrence M. Halpern more than expected).

Fields of papers citing papers by Lawrence M. Halpern

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lawrence M. Halpern. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lawrence M. Halpern. The network helps show where Lawrence M. Halpern may publish in the future.

Co-authorship network of co-authors of Lawrence M. Halpern

This figure shows the co-authorship network connecting the top 25 collaborators of Lawrence M. Halpern. A scholar is included among the top collaborators of Lawrence M. Halpern based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lawrence M. Halpern. Lawrence M. Halpern is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bjørstad, Petter E., Susanne C. Brenner, Lawrence M. Halpern, et al.. (2018). Domain Decomposition Methods in Science and Engineering XXIV. CERN Document Server (European Organization for Nuclear Research). 22 indexed citations

Halpern, Lawrence M. & Willie K. Dong. (1986). d-Phenylalanine: a putative enkephalinase inhibitor studied in a primate acute pain model. Pain. 24(2). 223–237. 10 indexed citations

Halpern, Lawrence M. & James Robinson. (1985). Prescribing Practices for Pain in Drug Dependence:. Advances in Alcohol & Substance Abuse. 5(1-2). 135–162. 20 indexed citations

Halpern, Lawrence M., et al.. (1979). The role of biogenic amines in amygdalar kindling. I. Local amygdalar afterdischarge.. Journal of Pharmacology and Experimental Therapeutics. 211(1). 151–158. 12 indexed citations

Halpern, Lawrence M., et al.. (1979). Turnover kinetics of dopamine and norepinephrine in the forebrain after kindling in rats. Neuropharmacology. 18(2). 219–222. 27 indexed citations

Halpern, Lawrence M.. (1978). Hashish: Studies of Long-Term Use. Anesthesiology. 48(5). 392–392. 30 indexed citations

Halpern, Lawrence M.. (1977). Analgesic Drugs in the Management of Pain. Archives of Surgery. 112(7). 861–861. 31 indexed citations

Troupin, Allan S., et al.. (1975). CARBAMAZEPINE (TEGRETOL) AS AN ANTICONVULSANT A CONTROLLED DOUBLE-BLIND COMPARISON WITH DIPHENYLHYDANTOIN (DILANTIN). Acta Neurologica Scandinavica. 51. 13–26. 22 indexed citations

Troupin, Allan S., et al.. (1974). Sulthiame: Evaluation as an Anticonvulsant. Epilepsia. 15(3). 329–349. 31 indexed citations

10.

Halpern, Lawrence M.. (1973). Analgesics and Other Drugs for Relief of Pain. Postgraduate Medicine. 53(6). 91–100. 1 indexed citations

11.

Halpern, Lawrence M., et al.. (1973). The Effect of Diphenylhydantoin on the Activity of Selected Enzymes in Chronic Isolated Cerebral Cortex of Cat. Epilepsia. 14(2). 223–232. 3 indexed citations

12.

Halpern, Lawrence M., et al.. (1973). Alterations in Enzyme Activity and Hyperexcitability in the Chronic Undercut Cerebral Cortex of Monkey*. Epilepsia. 14(2). 233–241. 1 indexed citations

13.

Julien, R. & Lawrence M. Halpern. (1972). Effects of Diphenylhydantoin and Other Antiepileptic Drugs on Epileptiform Activity and Purkinje Cell Discharge Rates. Epilepsia. 13(3). 387–400. 57 indexed citations

14.

Julien, R. & Lawrence M. Halpern. (1971). Diphenylhydantoin: Evidence for a central action. Life Sciences. 10(10). 575–582. 16 indexed citations

15.

Julien, R. & Lawrence M. Halpern. (1970). STABILIZATION OF EXCITABLE MEMBRANE BY CHRONIC ADMINISTRATION OF DIPHENYLHYDANTOIN. Journal of Pharmacology and Experimental Therapeutics. 175(1). 206–212. 5 indexed citations

16.

Halpern, Lawrence M. & Arthur A. Ward. (1969). The Hyperexcitable Neuron as a Model for the Laboratory Analysis of Anticonvulsant Drugs. Epilepsia. 10(2). 281–314. 6 indexed citations

17.

Halpern, Lawrence M. & Richard G. Black. (1969). GALLAMINE TRIETHIODIDE FACILITATION OF LOCAL CORTICAL EXCITABILITY COMPARED WITH OTHER NEUROMUSCULAR BLOCKING AGENTS. Survey of Anesthesiology. 13(3). 251–251. 11 indexed citations

18.

Halpern, Lawrence M. & Richard G. Black. (1968). GALLAMINE TRIETHIODIDE FACILITATION OF LOCAL CORTICAL EXCITABILITY COMPARED WITH OTHER NEUROMUSCULAR BLOCKING AGENTS. Journal of Pharmacology and Experimental Therapeutics. 162(1). 166–173. 18 indexed citations

19.

Halpern, Lawrence M. & Richard G. Black. (1967). Flaxedil (Gallamine Triethiodide): Evidence for a Central Action. Science. 155(3770). 1685–1687. 36 indexed citations

20.

Halpern, Lawrence M., et al.. (1957). The Effect of Chlorpromazine and the Modifying Action of Adrenaline on Human Capillaries. Stereotactic and Functional Neurosurgery. 17(1). 10–15. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact